BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 35068785)

  • 41. Comparison of revised EWGSOP criteria and four other diagnostic criteria of sarcopenia in Chinese community-dwelling elderly residents.
    Yang L; Yao X; Shen J; Sun G; Sun Q; Tian X; Li X; Li X; Ye L; Zhang Z; Dai J; Xiao H
    Exp Gerontol; 2020 Feb; 130():110798. PubMed ID: 31816424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upper thigh skeletal muscle index predicts outcomes in liver transplant recipients.
    Lim M; Kim JM; Yang J; Kwon J; Kim KD; Jeong ES; Rhu J; Choi GS; Joh JW; Lee SK
    Ann Surg Treat Res; 2023 Oct; 105(4):219-227. PubMed ID: 37908380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A multicenter study to define sarcopenia in patients with end-stage liver disease.
    Carey EJ; Lai JC; Wang CW; Dasarathy S; Lobach I; Montano-Loza AJ; Dunn MA;
    Liver Transpl; 2017 May; 23(5):625-633. PubMed ID: 28240805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications.
    Majeed T; Sharma B; Sharma R; Bodh V; Chauhan A; Surya M; Mir BA; Sharma N; Sharma D
    Indian J Gastroenterol; 2024 Jun; ():. PubMed ID: 38849681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Low Muscle Mass and Low Muscle Strength According to EWGSOP2 and EWGSOP1 in Community-Dwelling Older People.
    Costanzo L; De Vincentis A; Di Iorio A; Bandinelli S; Ferrucci L; Antonelli Incalzi R; Pedone C
    J Gerontol A Biol Sci Med Sci; 2020 Jun; 75(7):1324-1330. PubMed ID: 32157272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defining reference values for low skeletal muscle index at the L3 vertebra level based on computed tomography in healthy adults: A multicentre study.
    Kong M; Geng N; Zhou Y; Lin N; Song W; Xu M; Li S; Piao Y; Han Z; Guo R; Yang C; Luo N; Wang Z; Jiang M; Wang L; Qiu W; Li J; Shi D; Li R; Cheung EC; Chen Y; Duan Z
    Clin Nutr; 2022 Feb; 41(2):396-404. PubMed ID: 34999334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sarcopenia and sarcopenic obesity among community-dwelling Peruvian adults: A cross-sectional study.
    Flores-Flores O; Zevallos-Morales A; Pollard SL; Checkely W; Siddharthan T; Hurst JR; Bernabé-Ortiz A; Runzer-Colmenares FM; Witham M; Parodi JF
    Res Sq; 2023 Jun; ():. PubMed ID: 37398477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cirrhosis-related sarcopenia may not resolve after liver transplantation.
    Brown S; Richardson B; Bouquet E; Reid E; Mercer E; Goncalves M; Spann A; Annis J; Brittain E; Dreher A; Alexopoulos S; Slaughter JC; Silver HJ; Izzy M
    JHEP Rep; 2023 Nov; 5(11):100881. PubMed ID: 37771367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent sarcopenia definitions-prevalence, agreement and mortality associations among men: Findings from population-based cohorts.
    Westbury LD; Beaudart C; Bruyère O; Cauley JA; Cawthon P; Cruz-Jentoft AJ; Curtis EM; Ensrud K; Fielding RA; Johansson H; Kanis JA; Karlsson MK; Lane NE; Lengelé L; Lorentzon M; McCloskey E; Mellström D; Newman AB; Ohlsson C; Orwoll E; Reginster JY; Ribom E; Rosengren BE; Schousboe JT; Shiroma EJ; Harvey NC; Dennison EM; Cooper C;
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):565-575. PubMed ID: 36604970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis.
    Montano-Loza AJ; Duarte-Rojo A; Meza-Junco J; Baracos VE; Sawyer MB; Pang JX; Beaumont C; Esfandiari N; Myers RP
    Clin Transl Gastroenterol; 2015 Jul; 6(7):e102. PubMed ID: 26181291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase angle as a marker for muscle abnormalities and function in patients with colorectal cancer.
    Souza NC; Avesani CM; Prado CM; Martucci RB; Rodrigues VD; de Pinho NB; Heymsfield SB; Gonzalez MC
    Clin Nutr; 2021 Jul; 40(7):4799-4806. PubMed ID: 34271241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass.
    Trussardi Fayh AP; de Sousa IM
    PLoS One; 2021; 16(9):e0257446. PubMed ID: 34520502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis of Sarcopenia Using the L3 Skeletal Muscle Index Estimated From the L1 Skeletal Muscle Index on MR Images in Patients With Cirrhosis.
    Xu Z; Yang D; Luo J; Xu H; Jia J; Yang Z
    J Magn Reson Imaging; 2023 Nov; 58(5):1569-1578. PubMed ID: 36932680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis.
    Saeki C; Takano K; Oikawa T; Aoki Y; Kanai T; Takakura K; Nakano M; Torisu Y; Sasaki N; Abo M; Matsuura T; Tsubota A; Saruta M
    BMC Musculoskelet Disord; 2019 Dec; 20(1):615. PubMed ID: 31878909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cut-off points to screening for sarcopenia in community-dwelling older people residents in Brazil.
    Fernandes SGG; Lima de Andrade LE; Dos Santos Aguiar Gonçalves RS; Aires da Câmara SM; Guerra RO; Cavalcanti Maciel AC
    PeerJ; 2021; 9():e12038. PubMed ID: 34527442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparing EWGSOP2 and FNIH Sarcopenia Definitions: Agreement and 3-Year Survival Prognostic Value in Older Hospitalized Adults: The GLISTEN Study.
    Bianchi L; Maietti E; Abete P; Bellelli G; Bo M; Cherubini A; Corica F; Di Bari M; Maggio M; Martone AM; Rizzo MR; Rossi AP; Volpato S; Landi F;
    J Gerontol A Biol Sci Med Sci; 2020 Jun; 75(7):1331-1337. PubMed ID: 31628464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioimpedance analysis and physical functioning as mortality indicators among older sarcopenic people.
    Björkman MP; Pitkala KH; Jyväkorpi S; Strandberg TE; Tilvis RS
    Exp Gerontol; 2019 Jul; 122():42-46. PubMed ID: 31026498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancing ACLF prediction by integrating sarcopenia assessment and frailty in liver transplant candidates on the waiting list.
    Perdiguero GG; Spina JC; Martínez J; Savluk L; Saidman J; Bonifacio M; Bakken S; Padilla M; Gallego-Clemente E; Moreno-González V; De Santibañes M; Marciano S; De Santibañes E; Gadano A; Pekolj J; Abraldes JG; Mauro E
    JHEP Rep; 2024 Mar; 6(3):100985. PubMed ID: 38384670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sarcopenia is the independent predictor of mortality in critically ill patients with cirrhosis.
    Khan S; Benjamin J; Maiwall R; Tripathi H; Kapoor PB; Shasthry V; Saluja V; Agrawal P; Thapar S; Kumar G
    J Clin Transl Res; 2022 Jun; 8(3):200-208. PubMed ID: 35813898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of volume status on sarcopenia in non-dialysis chronic kidney disease patients.
    Kang SH; Kim JC; Cha RH; Han M; An WS; Kim SH; Do JY
    Sci Rep; 2022 Dec; 12(1):22289. PubMed ID: 36566275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.